Notizia - Recent Pharma, Healthcare and Biotech Happenings

MedTech News Updates for Renovia and Zsquare

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Zsquare ENT-Flex Rhinolaryngoscope Receives FDA Clearance; ClearMind Biomedical’s Completion of Least Invasive ICH Treatment; Bruker Launched Tool for ‘Long COVID’ Multi-Organ Risk Assessment; EarlySign, Roche Signed Strategic Deal; FDA Clearance for Leva® Pelvic Health System; NeuroOne’s Evo® sEEG Electrode

Explore More...
recent-pharma-biotech-news-updates-for-fosun-biontech-biomarin-Boston-Scientific

Fosun-BioNTech’s COVID-19 vaccine; Multiple Sclerosis research update; Vosoritide nabs FDA review; FDA nods to paclitaxel-coated Ranger balloon for PAD

pharma happenings for BMS Sanofi GW Pharmaceuticals Kiadis

Bristol Myers’ psoriasis drug; GW Pharmaceuticals eyes US market for Nabiximols; Karyopharm’s Xpovio; Kiadis USD 358M Buyout

recent-pharma-news-and-updates-for-novartis-gsk-exact-sciences-eqrx

Novartis taps Molecular Partners to combat COVID-19; GSK culls phase 2 asthma drug; Exact Sciences acquires Thrive for $ 2.15 B; EQRx-CStone’s deal for checkpoint inhibitors

Pharma news for Bayer, Novartis, Forma, AskBio

Bayer eyes AskBio’s Gene Therapies; Novartis’ Iptacopan; Forma’s IDH1-Mutated AML Therapy; EpicGenetics teams up with Mayo Clinic

Pharma news fro GSK, InCarda, BridgeBio

GSK’s RSV vaccine; SparingVision’s interest in gene therapy; InCarda’s raise; BridgeBio’s R&D deal

pharma-news-for-roche-prestige-covid-19

Venclexta full approval; PBP1510 Orphan Status; Roche/ Genesis collab; Immunomodulators for COVID-19

recent-pharma-news-updates-cyclerion-nimbus-dyno-rayzebio

Cyclerion’s olinciguat flunks sickle cell test; Nimbus nets $60M; Dyno-Roche’s gene therapy pact; RayzeBio debuts with $ 45M to target tumors

recent-pharma-news-and-updates-for-az-alkermes-innovent-lillys-avenue

US/AZ deal; Alkermes’ Schizophrenia drug; Innovent/Lilly’s China market expansion; Rejection for Avenue

recent-pharma-news-and-updates-for-santhera-merck-novartis-scribe

Santhera flunks DMD phase 3; Scribe emerges with $20 M; Merck sells off Osteoarthritis drug to Novartis; Research updates on flu vaccine and glioblastoma

MyoKardia & Eidos purchase; Amgen's Aimovig; HCV discovery; Bharat Biotech's Covaxin

MyoKardia buyout; Eidos acquisition; Amgen’s Aimovig; HCV discovery; Bharat Biotech’s Covaxin

recent-pharma-news-and-updates-for-moderna-pfizer-myovant-alnylam

Brain’s immune cells research update; Moderna’s COVID-19 vaccine; Pfizer funnels $200 M into CStone; Myovant’s relugolix falls short in metastatic prostate cancer; Alnylam’s lumasiran phase 3 result

recent-pharma-happenings-for-j-j-anokion-bms-roche

J&J ‘s COVID-19 vaccine; Roche, AC Immune’s anti-Tau Alzheimer’s drug; Silverback nets $85 M; Anokion’s deal rides out BMS-Celgene merger; Coronavirus spike protein could inspire vaccine development

Samsung/AZ Deal; Gyroscope’s GT005; Inflazome's Buyout; Abbott's MitraClip4; Grail Buyback

Samsung/AZ Deal; Gyroscope’s Dry AMD Gene Therapy; Inflazome’s Buyout; Abbott’s MitraClip4 EU Approval; Grail Buybacks

recent-pharma-happenings-for-eli-lilly-aziyo-biologics-bms

Lilly’s COVID-19 antibody reduces hospitalization rate; Tiny biologic drug to combat COVID-19; Aziyo Biologics files for $57.5 M IPO; BMS exercises option on Obsidian’s CD40L cell therapy

AZ corona Vaccine trial | Merck and Gilead Deal

While AZ resumes its COVID-19 vaccine trial in the UK; Merck and Gilead are busy making sizeable Breast cancer deals

recent-pharma-happenings-for-pfizer-biontech-oncoimmune-recursion

Pfizer-BioNTech COVID-19 vaccine trials; OncoImmune raises $56 M; Recursion Pharma nets $239 M; Breast cancer research updates

Subscribe to our Updates

DelveInsight is dedicated to safeguarding your data. We ensure that your information is handled in compliance with relevant data privacy legislation, our internal guidelines, and our privacy policy.

Receive recent Healthcare updates directly in your inbox.

Days
loader